Does nadir testosterone at the end of long term androgen deprivation therapy predict outcomes in high risk prostate cancer? Data from a phase III trial

@inproceedings{Nabid2017DoesNT,
  title={Does nadir testosterone at the end of long term androgen deprivation therapy predict outcomes in high risk prostate cancer? Data from a phase III trial},
  author={Abdenour Nabid and M.-P. Garant and A Mart{\'i}n and Dennis C. Shrieve and Marie Duclos and Jean-Paul Bahary and Christophe Lemaire and Sylvie Vass and Robert Archambault and François Andr{\'e} Vincent and Boris Bahoric and Redouane Bettahar},
  year={2017}
}

Similar Papers

Topics from this paper.